GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,999,000 | -2.7% | 68,911 | +0.9% | 0.44% | +0.5% |
Q1 2022 | $3,083,000 | -1.8% | 68,283 | -4.1% | 0.43% | -2.9% |
Q4 2021 | $3,139,000 | +16.5% | 71,183 | +1.0% | 0.45% | +14.0% |
Q3 2021 | $2,695,000 | +4318.0% | 70,489 | +4141.2% | 0.39% | +3820.0% |
Q4 2020 | $61,000 | -3.2% | 1,662 | +0.2% | 0.01% | -9.1% |
Q3 2020 | $63,000 | -7.4% | 1,658 | +0.1% | 0.01% | -8.3% |
Q2 2020 | $68,000 | +25.9% | 1,656 | +17.8% | 0.01% | +9.1% |
Q1 2020 | $54,000 | -18.2% | 1,406 | 0.0% | 0.01% | +10.0% |
Q4 2019 | $66,000 | +4.8% | 1,406 | -10.7% | 0.01% | -9.1% |
Q2 2019 | $63,000 | -99.9% | 1,575 | +11.0% | 0.01% | +37.5% |
Q3 2018 | $57,001,000 | – | 1,419 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |